Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Champions Oncolog (NQ: CSBR ) 4.720 -0.090 (-1.87%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Champions Oncolog < Previous 1 2 Next > Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million September 11, 2024 Via ACCESSWIRE Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 September 09, 2024 Via ACCESSWIRE Champions Oncology Reports Quarterly Revenue of $14.0 Million July 18, 2024 Via ACCESSWIRE Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024 July 11, 2024 Via ACCESSWIRE Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development June 04, 2024 Via ACCESSWIRE Champions Oncology Reports Quarterly Revenue of $13.1 Million July 24, 2023 Via ACCESSWIRE Champions Oncology Reports Quarterly Revenue of $12.9 Million July 21, 2022 Via ACCESSWIRE Champions Oncology Reports Quarterly Revenue of $12.0 Million March 12, 2024 Via ACCESSWIRE Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation March 07, 2024 Via ACCESSWIRE Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024 March 06, 2024 Via ACCESSWIRE Champions Oncology Reports Quarterly Revenue of $11.6 Million December 12, 2023 Via ACCESSWIRE Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023 December 04, 2023 Via ACCESSWIRE Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification November 02, 2023 Via ACCESSWIRE Champions Oncology Announces the Addition of Brady Davis as President October 17, 2023 Via ACCESSWIRE Champions Oncology Reports Quarterly Revenue of $12.6 Million September 13, 2023 Via ACCESSWIRE Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023 September 11, 2023 Via ACCESSWIRE Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023 August 22, 2023 Via ACCESSWIRE Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies August 01, 2023 Via ACCESSWIRE Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023 July 20, 2023 Via ACCESSWIRE Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development April 17, 2023 Via ACCESSWIRE Champions Oncology Announces $5M Stock Repurchase Program April 05, 2023 Via ACCESSWIRE Champions Oncology Reports Quarterly Revenue of $12.8 Million March 15, 2023 Via ACCESSWIRE Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023 March 13, 2023 Via ACCESSWIRE Champions Oncology Reports Record Quarterly Revenue of $14.3 Million December 13, 2022 Via ACCESSWIRE Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022 December 09, 2022 Via ACCESSWIRE Champions Oncology Reports Record Quarterly Revenue of $13.7 Million September 08, 2022 Via ACCESSWIRE Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022 September 06, 2022 Via ACCESSWIRE Champions Oncology Reports Quarterly Revenue of $12.9 Million July 21, 2022 Record Annual Revenue of $49.1 Million From Champions Oncology, Inc. Via AccessWire Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022 July 14, 2022 HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven... From Champions Oncology, Inc. Via AccessWire Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics May 31, 2022 HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative... From Champions Oncology, Inc. Via AccessWire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.